Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...

Avalere Health

- PMLiVE

NICE recommends Amgen’s Lumykras for non-small-cell lung cancer

Lung cancer is recorded as being the third most common cancer, with an estimated 48,000 new cases diagnosed in the UK every year

- PMLiVE

FDA issues final guidances for clinical cancer trials

The FDA is working to address inequities, target the right treatments to the right patients and speed progress against the most deadly and rare cancers

Onyx Health Announces a “Double Hatrick” of New Appointments

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Onyx Health

Utilising Patient Insight in Pharma Marketing

The importance in understanding the patients view point when marketing in Pharma (Article written August 30th 2021)

Dice Medical Communications

Office move signals new era for Berkshire agency

Dice Medical Communications moves office due to business growth

Dice Medical Communications

How Ease of Access to HES Data Benefits HCPs & Key NHS Stakeholders

Article written August 27th 2021

Dice Medical Communications

How a Copywriter Reads a Clinical Paper

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

Dice Medical Communications

What does HCP engagement look like in a post-Covid world?

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Dice Medical Communications

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Lucid Group Communications Limited

- PMLiVE

AbbVie acquires Syndesi Therapeutics in $1bn deal

The deal will allow AbbVie to access Syndesi’s research into Alzheimer's disease

- PMLiVE

Verily Life Science signs new contract with Oncimmune for long COVID study

The project will analyse potential patterns of autoantibodies, which are associated with developing long COVID

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links